SCHEMBL484541

SCHEMBL484541

O=C(NC1CCc2ccc(C(=O)N3CCC4(CCN(CCc5ccccc5)CC4)CC3)cc21)c1cccc(Cl)c1Cl

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 3/20 0.44
TAS1R1 Q7RTX1 3/20 0.44
TAS1R2 Q8TE23 3/20 0.44
KCNH2 Q12809 9/20 0.43
HTR1A P08908 7/20 0.43
DRD2 P14416 7/20 0.43
HTR2A P28223 7/20 0.43
CHRM2 P08172 2/20 0.42
CHRM3 P20309 2/20 0.42
CYP2D6 P10635 2/20 0.42
MAPK1 P28482 1/20 0.42
CCR8 P51685 1/20 0.40
DRD4 P21917 1/20 0.40
ACKR3 P25106 1/20 0.39
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL484646 0.95 TAS1R3 (0.43) TAS1R3TAS1R1TAS1R2KCNH2HTR1A
SCHEMBL2816014 0.89 DRD2 (0.43) TAS1R3TAS1R1TAS1R2KCNH2HTR1A
SCHEMBL484680 0.89 CYP2D6 (0.44) TAS1R3TAS1R1TAS1R2KCNH2HTR1A
SCHEMBL2815768 0.87 KCNH2 (0.46) KCNH2HTR1ADRD2HTR2ACHRM2
SCHEMBL484362 0.86 USP2 (0.46) KCNH2HTR1ADRD2HTR2ACHRM2
SCHEMBL484553 0.86 CYP2D6 (0.49) TAS1R3TAS1R1TAS1R2CYP2D6MAPK1
SCHEMBL484772 0.85 DRD2 (0.42) TAS1R3TAS1R1TAS1R2KCNH2HTR1A
SCHEMBL2815754 0.85 GABRD (0.46) TAS1R3TAS1R1TAS1R2
SCHEMBL484806 0.85 ACHE (0.43) TAS1R3TAS1R1TAS1R2KCNH2CHRM2
SCHEMBL485017 0.84 CYP2D6 (0.40) TAS1R3TAS1R1TAS1R2KCNH2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US claimed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US claimed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP claimed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US claimed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO claimed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN TAS1R3 339/4885TAS1R1 107/4885TAS1R2 282/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN TAS1R3 339/4885TAS1R1 107/4885TAS1R2 282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.